MHRA Drug Safety Update July 2022

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 15 Issue 12 July 2022) has been published and includes articles on:

  • Topiramate (Topamax): start of safety review triggered by a study reporting an increased risk of neurodevelopmental disabilities in children with prenatal exposure
  • COVID-19 vaccines and medicines: updates for July 2022
  • Letters and medicine recalls sent to healthcare professionals in June 2022

To see the latest MHRA Drug Safety Updates in full, visit the website

Discover how we are working to improve the outlook for community pharmacy at an event near you.

Click Here